AVAH 250117 7.50C (AVAH250117C7500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

AVAH250117C7500

Watchlist

0.20
0.000.00%

15min DelayClose Dec 20 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Aveanna to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire07:30 ET
Analysts Conflicted on These Healthcare Names: Aveanna Healthcare Holdings (AVAH) and BioNTech SE (BNTX)
TipRanksNov 26 08:50 ET · Ratings
Truist Financial Maintains Aveanna Healthcare(AVAH.US) With Hold Rating, Announces Target Price $6
Moomoo NewsNov 15 07:31 ET · Ratings
Truist Financial Reaffirms Their Hold Rating on Aveanna Healthcare Holdings (AVAH)
TipRanksNov 15 07:06 ET · Ratings
NASDAQ New 52-Week Highs And Lows
Dow JonesNov 12 11:21 ET
UBS Maintains Aveanna Healthcare(AVAH.US) With Sell Rating, Raises Target Price to $3.2
Moomoo NewsNov 9 02:31 ET · Ratings

Comments

Iwill TradeScared

Oct 15 18:59

$Aveanna Healthcare (AVAH.US)$ testing

Iwill TradeScared

Oct 9 19:46

$Aveanna Healthcare (AVAH.US)$

Tonyco

Oct 6 12:11

Columns Cause and Effect

Oh, no, numbers did a thing!!!! PAN8C SELL
Anticipating rate cuts in September, businesses increased payrolls by re-hiring all the people they laid off earlier in the year or later to "protect margins."
Why wouldn't you try to get a head start on boosted demand for products?
Predictably, Old Money doesn't think past the week, so if nothing else, next week, will present entry points.
$ChromaDex (CDXC.US)$ Bioscience, aging products.
FY24 Estimates:
Sales growth +13% yoy
Gross marg...

September new jobs higher than expected, is this a 'soft landing' ?

Tonyco

Oct 5 22:23

$Aveanna Healthcare (AVAH.US)$
Estimates for FY24:
Sales growth : +5% YoY
EBITDA: +16% YoY
Net Income : +106% YoY
EPS + 104% YoY

Moomoo AI

Dec 13, 2023 04:40

Despite Aveanna Healthcare's recent rally, its P/S ratio remains low amid predictions its growth will lag industry standards. This suggests investor expectation of limited future growth and a reluctance to pay more for its current state, likely averting a substantial price rise soon.

Aveanna Healthcare Holdings Inc.'s (NASDAQ:AVAH) Price Is Right But Growth Is Lacking After Shares Rocket 46%